ELRL-MD: a deep learning approach for myocarditis diagnosis using cardiac magnetic resonance images with ensemble and reinforcement learning integration.

Objective.Myocarditis poses a significant health risk, often precipitated by viral infections like coronavirus disease, and can lead to fatal cardiac complications. As a less invasive alternative to the standard diagnostic practice of endomyocardial biopsy, which is highly invasive and thus limited to severe cases, cardiac magnetic resonance (CMR) imaging offers a promising solution for detecting myocardial abnormalities.Approach.This study introduces a deep model called ELRL-MD that combines ensemble learning and reinforcement learning (RL) for effective myocarditis diagnosis from CMR images. The model begins with pre-training via the artificial bee colony (ABC) algorithm to enhance the starting point for learning. An array of convolutional neural networks (CNNs) then works in concert to extract and integrate features from CMR images for accurate diagnosis. Leveraging the Z-Alizadeh Sani myocarditis CMR dataset, the model employs RL to navigate the dataset's imbalance by conceptualizing diagnosis as a decision-making process.Main results.ELRL-DM demonstrates remarkable efficacy, surpassing other deep learning, conventional machine learning, and transfer learning models, achieving an F-measure of 88.2% and a geometric mean of 90.6%. Extensive experimentation helped pinpoint the optimal reward function settings and the perfect count of CNNs.Significance.The study addresses the primary technical challenge of inherent data imbalance in CMR imaging datasets and the risk of models converging on local optima due to suboptimal initial weight settings. Further analysis, leaving out ABC and RL components, confirmed their contributions to the model's overall performance, underscoring the effectiveness of addressing these critical technical challenges.

Deep learning-accelerated T2WI: image quality, efficiency, and staging performance against BLADE T2WI for gastric cancer.

PURPOSE: The purpose of our study is to investigate image quality, efficiency, and diagnostic performance of a deep learning-accelerated single-shot breath-hold (DLSB) against BLADE for T2-weighted MR imaging (T2WI) for gastric cancer (GC). METHODS: 112 patients with GCs undergoing gastric MRI were prospectively enrolled between Aug 2022 and Dec 2022. Axial DLSB-T2WI and BLADE-T2WI of stomach were scanned with same spatial resolution. Three radiologists independently evaluated the image qualities using a 5-scale Likert scales (IQS) in terms of lesion delineation, gastric wall boundary conspicuity, and overall image quality. Signal-to-noise ratio (SNR) and contrast-to-noise ratio (CNR) were calculated in measurable lesions. T staging was conducted based on the results of both sequences for GC patients with gastrectomy. Pairwise comparisons between DLSB-T2WI and BLADE-T2WI were performed using the Wilcoxon signed-rank test, paired t-test, and chi-squared test. Kendall's W, Fleiss' Kappa, and intraclass correlation coefficient values were used to determine inter-reader reliability. RESULTS: Against BLADE, DLSB reduced total acquisition time of T2WI from 495 min (mean 4:42 per patient) to 33.6 min (18 s per patient), with better overall image quality that produced 9.43-fold, 8.00-fold, and 18.31-fold IQS upgrading against BALDE, respectively, in three readers. In 69 measurable lesions, DLSB-T2WI had higher mean SNR and higher CNR than BLADE-T2WI. Among 71 patients with gastrectomy, DLSB-T2WI resulted in comparable accuracy to BLADE-T2WI in staging GCs (P > 0.05). CONCLUSIONS: DLSB-T2WI demonstrated shorter acquisition time, better image quality, and comparable staging accuracy, which could be an alternative to BLADE-T2WI for gastric cancer imaging.

DF-dRVFL: A novel deep feature based classifier for breast mass classification.

Amongst all types of cancer, breast cancer has become one of the most common cancers in the UK threatening millions of people's health. Early detection of breast cancer plays a key role in timely treatment for morbidity reduction. Compared to biopsy, which takes tissues from the lesion for further analysis, image-based methods are less time-consuming and pain-free though they are hampered by lower accuracy due to high false positivity rates. Nevertheless, mammography has become a standard screening method due to its high efficiency and low cost with promising performance. Breast mass, as the most palpable symptom of breast cancer, has received wide attention from the community. As a result, the past decades have witnessed the speeding development of computer-aided systems that are aimed at providing radiologists with useful tools for breast mass analysis based on mammograms. However, the main issues of these systems include low accuracy and require enough computational power on a large scale of datasets. To solve these issues, we developed a novel breast mass classification system called DF-dRVFL. On the public dataset DDSM with more than 3500 images, our best model based on deep random vector functional link network showed promising results through five-cross validation with an averaged AUC of 0.93 and an average accuracy of 81.71%. Compared to sole deep learning based methods, average accuracy has increased by 0.38. Compared with the state-of-the-art methods, our method showed better performance considering the number of images for evaluation and the overall accuracy.

Role of Additional MRI-Based Morphologic Measurements on the Performance of VI-RADS for Muscle-Invasive Bladder Cancer.

BACKGROUND: Vesical Imaging-Reporting and Data System (VI-RADS) is a pathway for the standardized imaging and reporting of bladder cancer staging using multiparametric (mp) MRI. PURPOSE: To investigate additional role of morphological (MOR) measurements to VI-RADS for the detection of muscle-invasive bladder cancer (MIBC) with mpMRI. STUDY TYPE: Retrospective. POPULATION: A total of 198 patients (72 MIBC and 126 NMIBC) underwent bladder mpMRI was included. FIELD STRENGTH/SEQUENCE: 3.0 T/T2-weighted imaging with fast-spin-echo sequence, spin-echo-planar diffusion-weighted imaging and dynamic contrast-enhanced imaging with fast 3D gradient-echo sequence. ASSESSMENT: VI-RADS score and MOR measurement including tumor location, number, stalk, cauliflower-like surface, type of tumor growth, tumor-muscle contact margin (TCM), tumor-longitudinal length (TLL), and tumor cellularity index (TCI) were analyzed by three uroradiologists (3-year, 8-year, and 15-year experience of bladder MRI, respectively) who were blinded to histopathology. STATISTICAL TESTS: Significant MOR measurements associated with MIBC were tested by univariable and multivariable logistic regression (LR) analysis with odds ratio (OR). Area under receiver operating characteristic curve (AUC) with DeLong's test and decision curve analysis (DCA) were used to compared the performance of unadjusted vs. adjusted VI-RADS. A P-value <0.05 was considered statistically significant. RESULTS: TCM (OR 9.98; 95% confidence interval [CI] 4.77-20.8), TCI (OR 5.72; 95% CI 2.37-13.8), and TLL (OR 3.35; 95% CI 1.40-8.03) were independently associated with MIBC at multivariable LR analysis. VI-RADS adjusted by three MORs achieved significantly higher AUC (reader 1 0.908 vs. 0.798; reader 2 0.906 vs. 0.855; reader 3 0.907 vs. 0.831) and better clinical benefits than unadjusted VI-RADS at DCA. Specially in VI-RADS-defined equivocal lesions, MOR-based adjustment resulted in 55.5% (25/45), 70.4% (38/54), and 46.4% (26/56) improvement in accuracy for discriminating MIBC in three readers, respectively. DATA CONCLUSION: MOR measurements improved the performance of VI-RADS in detecting MIBC with mpMRI, especially for equivocal lesions. LEVEL OF EVIDENCE: 3 TECHNICAL EFFICACY: Stage 2.

Lung-PNet: An Automated Deep Learning Model for the Diagnosis of Invasive Adenocarcinoma in Pure Ground-Glass Nodules on Chest CT.

BACKGROUND. Pure ground-glass nodules (pGGNs) on chest CT representing invasive adenocarcinoma (IAC) warrant lobectomy with lymph node resection. For pGGNs representing other entities, close follow-up or sublobar resection without node dissection may be appropriate. OBJECTIVE. The purpose of this study was to develop and validate an automated deep learning model for differentiation of pGGNs on chest CT representing IAC from those representing atypical adenomatous hyperplasia (AAH), adenocarcinoma in situ (AIS), and minimally invasive adenocarcinoma (MIA). METHODS. This retrospective study included 402 patients (283 women, 119 men; mean age, 53.2 years) with a total of 448 pGGNs on noncontrast chest CT that were resected from January 2019 to June 2022 and were histologically diagnosed as AAH (n = 29), AIS (n = 83), MIA (n = 235), or IAC (n = 101). Lung-PNet, a 3D deep learning model, was developed for automatic segmentation and classification (probability of IAC vs other entities) of pGGNs on CT. Nodules resected from January 2019 to December 2021 were randomly allocated to training (n = 327) and internal test (n = 82) sets. Nodules resected from January 2022 to June 2022 formed a holdout test set (n = 39). Segmentation performance was assessed with Dice coefficients with radiologists' manual segmentations as reference. Classification performance was assessed by ROC AUC and precision-recall AUC (PR AUC) and compared with that of four readers (three radiologists, one surgeon). The code used is publicly available (https://github.com/XiaodongZhang-PKUFH/Lung-PNet.git). RESULTS. In the holdout test set, Dice coefficients for segmentation of IACs and of other lesions were 0.860 and 0.838, and ROC AUC and PR AUC for classification as IAC were 0.911 and 0.842. At threshold probability of 50.0% or greater for prediction of IAC, Lung-PNet had sensitivity, specificity, accuracy, and F1 score of 50.0%, 92.0%, 76.9%, and 60.9% in the holdout test set. In the holdout test set, accuracy and F1 score (p values vs Lung-PNet) for individual readers were as follows: reader 1, 51.3% (p = .02) and 48.6% (p = .008); reader 2, 79.5% (p = .75) and 75.0% (p = .10); reader 3, 66.7% (p = .35) and 68.3% (p < .001); reader 4, 71.8% (p = .48) and 42.1% (p = .18). CONCLUSION. Lung-PNet had robust performance for segmenting and classifying (IAC vs other entities) pGGNs on chest CT. CLINICAL IMPACT. This automated deep learning tool may help guide selection of surgical strategies for pGGN management.

Catalytic Asymmetric Polycyclization of Tertiary Enamides with Silyl Enol Ethers: Total Synthesis of (-)-Cephalocyclidin A.

A catalytic enantioselective polycyclization of tertiary enamides with terminal silyl enol ethers has been developed by virtue of Cu(OTf)2 catalysis with a novel spiropyrroline-derived oxazole (SPDO) ligand. This tandem reaction offers an effective approach to assemble bicyclic and tricyclic N-heterocycles bearing both aza- and oxa-quaternary stereogenic centers, which are primal subunits in a range of natural alkaloids. Strategic application of this methodology and a late-stage radical cyclization as key steps have been showcased in the concise total synthesis of (-)-cephalocyclidin A.

Empowering Foot Health: Harnessing the Adaptive Weighted Sub-Gradient Convolutional Neural Network for Diabetic Foot Ulcer Classification.

In recent times, DFU (diabetic foot ulcer) has become a universal health problem that affects many diabetes patients severely. DFU requires immediate proper treatment to avert amputation. Clinical examination of DFU is a tedious process and complex in nature. Concurrently, DL (deep learning) methodologies can show prominent outcomes in the classification of DFU because of their efficient learning capacity. Though traditional systems have tried using DL-based models to procure better performance, there is room for enhancement in accuracy. Therefore, the present study uses the AWSg-CNN (Adaptive Weighted Sub-gradient Convolutional Neural Network) method to classify DFU. A DFUC dataset is considered, and several processes are involved in the present study. Initially, the proposed method starts with pre-processing, excluding inconsistent and missing data, to enhance dataset quality and accuracy. Further, for classification, the proposed method utilizes the process of RIW (random initialization of weights) and log softmax with the ASGO (Adaptive Sub-gradient Optimizer) for effective performance. In this process, RIW efficiently learns the shift of feature space between the convolutional layers. To evade the underflow of gradients, the log softmax function is used. When logging softmax with the ASGO is used for the activation function, the gradient steps are controlled. An adaptive modification of the proximal function simplifies the learning rate significantly, and optimal proximal functions are produced. Due to such merits, the proposed method can perform better classification. The predicted results are displayed on the webpage through the HTML, CSS, and Flask frameworks. The effectiveness of the proposed system is evaluated with accuracy, recall, F1-score, and precision to confirm its effectual performance.

Biopsy-free AI-aided precision MRI assessment in prediction of prostate cancer biochemical recurrence.

BACKGROUND: To investigate the predictive ability of high-throughput MRI with deep survival networks for biochemical recurrence (BCR) of prostate cancer (PCa) after prostatectomy. METHODS: Clinical-MRI and histopathologic data of 579 (train/test, 463/116) PCa patients were retrospectively collected. The deep survival network (iBCR-Net) is based on stepwise processing operations, which first built an MRI radiomics signature (RadS) for BCR, and predicted the T3 stage and lymph node metastasis (LN+) of tumour using two predefined AI models. Subsequently, clinical, imaging and histopathological variables were integrated into iBCR-Net for BCR prediction. RESULTS: RadS, derived from 2554 MRI features, was identified as an independent predictor of BCR. Two predefined AI models achieved an accuracy of 82.6% and 78.4% in staging T3 and LN+. The iBCR-Net, when expressed as a presurgical model by integrating RadS, AI-diagnosed T3 stage and PSA, can match a state-of-the-art histopathological model (C-index, 0.81 to 0.83 vs 0.79 to 0.81, p > 0.05); and has maximally 5.16-fold, 12.8-fold, and 2.09-fold (p < 0.05) benefit to conventional D'Amico score, the Cancer of the Prostate Risk Assessment (CAPRA) score and the CAPRA Postsurgical score. CONCLUSIONS: AI-aided iBCR-Net using high-throughput MRI can predict PCa BCR accurately and thus may provide an alternative to the conventional method for PCa risk stratification.

Immuno-genomic-radiomics to predict response of biliary tract cancer to camrelizumab plus GEMOX in a single-arm phase II trial.

Background & Aims: Immunotherapy is an option for the treatment of advanced biliary tract cancer (BTC), although it has a low response rate. In this post hoc analysis, we investigated the predictive value of an immuno-genomic-radiomics (IGR) analysis for patients with BTC treated with camrelizumab plus gemcitabine and oxaliplatin (GEMOX) therapy. Methods: Thirty-two patients with BTC treated with camrelizumab plus GEMOX were prospectively enrolled. The relationship between high-throughput computed tomography (CT) radiomics features with immuno-genomic expression was tested and scaled with a full correlation matrix analysis. Odds ratio (OR) of IGR expression for objective response to camrelizumab plus GEMOX was tested with logistic regression analysis. Association of IGR expression with progression-free survival (PFS) and overall survival (OS) was analysed with a Cox proportional hazard regression. Results: CT radiomics correlated with CD8+ T cells (r = -0.72-0.71, p = 0.004-0.047), tumour mutation burden (TMB) (r = 0.59, p = 0.039), and ARID1A mutation (r = -0.58-0.57, p = 0.020-0.034). There was no significant correlation between radiomics and programmed cell death protein ligand 1 expression (p >0.96). Among all IGR biomarkers, only four radiomics features were independent predictors of objective response (OR = 0.09-3.81; p = 0.011-0.044). Combining independent radiomics features into an objective response prediction model achieved an area under the curve of 0.869. In a Cox analysis, radiomics signature [hazard ratio (HR) = 6.90, p <0.001], ARID1A (HR = 3.31, p = 0.013), and blood TMB (HR = 1.13, p = 0.023) were independent predictors of PFS. Radiomics signature (HR = 6.58, p <0.001) and CD8+ T cells (HR = 0.22, p = 0.004) were independent predictors of OS. Prognostic models integrating these features achieved concordance indexes of 0.677 and 0.681 for PFS and OS, respectively. Conclusions: Radiomics could act as a non-invasive immuno-genomic surrogate of BTC, which could further aid in response prediction for patients with BTC treated with immunotherapy. However, multicenter and larger sample studies are required to validate these results. Impact and implications: Immunotherapy is an alternative for the treatment of advanced BTC, whereas tumour response is heterogeneous. In a post hoc analysis of the single-arm phase II clinical trial (NCT03486678), we found that CT radiomics features were associated with the tumour microenvironment and that IGR expression was a promising marker for tumour response and long-term survival. Clinical trial number: Post hoc analysis of NCT03486678.

Automatic diagnosis of COVID-19 from CT images using CycleGAN and transfer learning.

The outbreak of the corona virus disease (COVID-19) has changed the lives of most people on Earth. Given the high prevalence of this disease, its correct diagnosis in order to quarantine patients is of the utmost importance in the steps of fighting this pandemic. Among the various modalities used for diagnosis, medical imaging, especially computed tomography (CT) imaging, has been the focus of many previous studies due to its accuracy and availability. In addition, automation of diagnostic methods can be of great help to physicians. In this paper, a method based on pre-trained deep neural networks is presented, which, by taking advantage of a cyclic generative adversarial net (CycleGAN) model for data augmentation, has reached state-of-the-art performance for the task at hand, i.e., 99.60% accuracy. Also, in order to evaluate the method, a dataset containing 3163 images from 189 patients has been collected and labeled by physicians. Unlike prior datasets, normal data have been collected from people suspected of having COVID-19 disease and not from data from other diseases, and this database is made available publicly. Moreover, the method's reliability is further evaluated by calibration metrics, and its decision is interpreted by Grad-CAM also to find suspicious regions as another output of the method and make its decisions trustworthy and explainable.

A Survey of Convolutional Neural Network in Breast Cancer.

Problems: For people all over the world, cancer is one of the most feared diseases. Cancer is one of the major obstacles to improving life expectancy in countries around the world and one of the biggest causes of death before the age of 70 in 112 countries. Among all kinds of cancers, breast cancer is the most common cancer for women. The data showed that female breast cancer had become one of the most common cancers. Aims: A large number of clinical trials have proved that if breast cancer is diagnosed at an early stage, it could give patients more treatment options and improve the treatment effect and survival ability. Based on this situation, there are many diagnostic methods for breast cancer, such as computer-aided diagnosis (CAD). Methods: We complete a comprehensive review of the diagnosis of breast cancer based on the convolutional neural network (CNN) after reviewing a sea of recent papers. Firstly, we introduce several different imaging modalities. The structure of CNN is given in the second part. After that, we introduce some public breast cancer data sets. Then, we divide the diagnosis of breast cancer into three different tasks: 1. classification; 2. detection; 3. segmentation. Conclusion: Although this diagnosis with CNN has achieved great success, there are still some limitations. (i) There are too few good data sets. A good public breast cancer dataset needs to involve many aspects, such as professional medical knowledge, privacy issues, financial issues, dataset size, and so on. (ii) When the data set is too large, the CNN-based model needs a sea of computation and time to complete the diagnosis. (iii) It is easy to cause overfitting when using small data sets.

BRMI-Net: Deep Learning Features and Flower Pollination-Controlled Regula Falsi-Based Feature Selection Framework for Breast Cancer Recognition in Mammography Images.

The early detection of breast cancer using mammogram images is critical for lowering women's mortality rates and allowing for proper treatment. Deep learning techniques are commonly used for feature extraction and have demonstrated significant performance in the literature. However, these features do not perform well in several cases due to redundant and irrelevant information. We created a new framework for diagnosing breast cancer using entropy-controlled deep learning and flower pollination optimization from the mammogram images. In the proposed framework, a filter fusion-based method for contrast enhancement is developed. The pre-trained ResNet-50 model is then improved and trained using transfer learning on both the original and enhanced datasets. Deep features are extracted and combined into a single vector in the following phase using a serial technique known as serial mid-value features. The top features are then classified using neural networks and machine learning classifiers in the following stage. To accomplish this, a technique for flower pollination optimization with entropy control has been developed. The exercise used three publicly available datasets: CBIS-DDSM, INbreast, and MIAS. On these selected datasets, the proposed framework achieved 93.8, 99.5, and 99.8% accuracy, respectively. Compared to the current methods, the increase in accuracy and decrease in computational time are explained.

GAM-SpCaNet: Gradient awareness minimization-based spinal convolution attention network for brain tumor classification.

Brain tumor is one of the common diseases of the central nervous system, with high morbidity and mortality. Due to the wide range of brain tumor types and pathological types, the same type is divided into different subgrades. The imaging manifestations are complex, making clinical diagnosis and treatment difficult. In this paper, we construct SpCaNet (Spinal Convolution Attention Network) to effectively utilize the pathological features of brain tumors, consisting of a Positional Attention (PA) convolution block, Relative self-attention transformer block, and Intermittent fully connected (IFC) layer. Our method is more lightweight and efficient in recognition of brain tumors. Compared with the SOTA model, the number of parameters is reduced by more than three times. In addition, we propose the gradient awareness minimization (GAM) algorithm to solve the problem of insufficient generalization ability of the traditional Stochastic Gradient Descent (SGD) method and use it to train the SpCaNet model. Compared with SGD, GAM achieves better classification performance. According to the experimental results, our method has achieved the highest accuracy of 99.28%, and the proposed method performs well in classifying brain tumors.

Automated diagnosis of cardiovascular diseases from cardiac magnetic resonance imaging using deep learning models: A review.

In recent years, cardiovascular diseases (CVDs) have become one of the leading causes of mortality globally. At early stages, CVDs appear with minor symptoms and progressively get worse. The majority of people experience symptoms such as exhaustion, shortness of breath, ankle swelling, fluid retention, and other symptoms when starting CVD. Coronary artery disease (CAD), arrhythmia, cardiomyopathy, congenital heart defect (CHD), mitral regurgitation, and angina are the most common CVDs. Clinical methods such as blood tests, electrocardiography (ECG) signals, and medical imaging are the most effective methods used for the detection of CVDs. Among the diagnostic methods, cardiac magnetic resonance imaging (CMRI) is increasingly used to diagnose, monitor the disease, plan treatment and predict CVDs. Coupled with all the advantages of CMR data, CVDs diagnosis is challenging for physicians as each scan has many slices of data, and the contrast of it might be low. To address these issues, deep learning (DL) techniques have been employed in the diagnosis of CVDs using CMR data, and much research is currently being conducted in this field. This review provides an overview of the studies performed in CVDs detection using CMR images and DL techniques. The introduction section examined CVDs types, diagnostic methods, and the most important medical imaging techniques. The following presents research to detect CVDs using CMR images and the most significant DL methods. Another section discussed the challenges in diagnosing CVDs from CMRI data. Next, the discussion section discusses the results of this review, and future work in CVDs diagnosis from CMR images and DL techniques are outlined. Finally, the most important findings of this study are presented in the conclusion section.

Multiple-level thresholding for breast mass detection.

Detection of breast mass plays a very important role in making the diagnosis of breast cancer. For faster detection of breast cancer caused by breast mass, we developed a novel and efficient patch-based breast mass detection system for mammography images. The proposed framework is comprised of three modules, including pre-processing, multiple-level breast tissue segmentation, and final breast mass detection. An improved Deeplabv3+ model for pectoral muscle removal is deployed in pre-processing. We then proposed a multiple-level thresholding segmentation method to segment breast mass and obtained the connected components (ConCs), where the corresponding image patch to each ConC is extracted for mass detection. In the final detection stage, each image patch is classified into breast mass and breast tissue background by trained deep learning models. The patches that are classified as breast mass are then taken as the candidates for breast mass. To reduce the false positive rate in the detection results, we applied the non-maximum suppression algorithm to combine the overlapped detection results. Once an image patch is considered a breast mass, the accurate detection result can then be retrieved from the corresponding ConC in the segmented images. Moreover, a coarse segmentation result can be simultaneously retrieved after detection. Compared to the state-of-the-art methods, the proposed method achieved comparable performance. On CBIS-DDSM, the proposed method achieved a detection sensitivity of 0.87 at 2.86 FPI (False Positive rate per Image), while the sensitivity reached 0.96 on INbreast with an FPI of only 1.29.

CTMLP: Can MLPs replace CNNs or transformers for COVID-19 diagnosis?

BACKGROUND: Convolutional Neural Networks (CNNs) and the hybrid models of CNNs and Vision Transformers (VITs) are the recent mainstream methods for COVID-19 medical image diagnosis. However, pure CNNs lack global modeling ability, and the hybrid models of CNNs and VITs have problems such as large parameters and computational complexity. These models are difficult to be used effectively for medical diagnosis in just-in-time applications. METHODS: Therefore, a lightweight medical diagnosis network CTMLP based on convolutions and multi-layer perceptrons (MLPs) is proposed for the diagnosis of COVID-19. The previous self-supervised algorithms are based on CNNs and VITs, and the effectiveness of such algorithms for MLPs is not yet known. At the same time, due to the lack of ImageNet-scale datasets in the medical image domain for model pre-training. So, a pre-training scheme TL-DeCo based on transfer learning and self-supervised learning was constructed. In addition, TL-DeCo is too tedious and resource-consuming to build a new model each time. Therefore, a guided self-supervised pre-training scheme was constructed for the new lightweight model pre-training. RESULTS: The proposed CTMLP achieves an accuracy of 97.51%, an f1-score of 97.43%, and a recall of 98.91% without pre-training, even with only 48% of the number of ResNet50 parameters. Furthermore, the proposed guided self-supervised learning scheme can improve the baseline of simple self-supervised learning by 1%-1.27%. CONCLUSION: The final results show that the proposed CTMLP can replace CNNs or Transformers for a more efficient diagnosis of COVID-19. In addition, the additional pre-training framework was developed to make it more promising in clinical practice.

ReRNet: A Deep Learning Network for Classifying Blood Cells.

AIMS: Blood cell classification helps detect various diseases. However, the current classification model of blood cells cannot always get great results. A network that automatically classifies blood cells can provide doctors with data as one of the criteria for diagnosing patients' disease types and severity. If doctors diagnose blood cells, doctors could spend lots of time on the diagnosis. The diagnosis progress is very tedious. Doctors can make some mistakes when they feel tired. On the other hand, different doctors may have different points on the same patient. METHODS: We propose a ResNet50-based ensemble of randomized neural networks (ReRNet) for blood cell classification. ResNet50 is used as the backbone model for feature extraction. The extracted features are fed to 3 randomized neural networks (RNNs): Schmidt neural network, extreme learning machine, and dRVFL. The outputs of the ReRNet are the ensemble of these 3 RNNs based on the majority voting mechanism. The 5 × 5-fold cross-validation is applied to validate the proposed network. RESULTS: The average-accuracy, average-sensitivity, average-precision, and average-F1-score are 99.97%, 99.96%, 99.98%, and 99.97%, respectively. CONCLUSIONS: The ReRNet is compared with 4 state-of-the-art methods and achieves the best classification performance. The ReRNet is an effective method for blood cell classification based on these results.

An Evolutionary Attention-Based Network for Medical Image Classification.

Deep learning has become a primary choice in medical image analysis due to its powerful representation capability. However, most existing deep learning models designed for medical image classification can only perform well on a specific disease. The performance drops dramatically when it comes to other diseases. Generalizability remains a challenging problem. In this paper, we propose an evolutionary attention-based network (EDCA-Net), which is an effective and robust network for medical image classification tasks. To extract task-related features from a given medical dataset, we first propose the densely connected attentional network (DCA-Net) where feature maps are automatically channel-wise weighted, and the dense connectivity pattern is introduced to improve the efficiency of information flow. To improve the model capability and generalizability, we introduce two types of evolution: intra- and inter-evolution. The intra-evolution optimizes the weights of DCA-Net, while the inter-evolution allows two instances of DCA-Net to exchange training experience during training. The evolutionary DCA-Net is referred to as EDCA-Net. The EDCA-Net is evaluated on four publicly accessible medical datasets of different diseases. Experiments showed that the EDCA-Net outperforms the state-of-the-art methods on three datasets and achieves comparable performance on the last dataset, demonstrating good generalizability for medical image classification.